Businessman Marc Coucke has invested 40 million euros in the Liège pharmaceutical company Mithra. Coucke is now the second largest shareholder, behind his Walloon counterpart, CEO François Fornieri. Coucke was appointed as chairman of the Strategic Committee of Mithra Pharmaceuticals on January 26th, to prepare the IPO of the company. The money will be invested in the R&D activities of the group. The company’s showpiece is the contraceptive pill Estelle, based on the natural hormone esterol.
BioVox
With a local focus and global reach, BioVox shares insights into the Belgian life sciences ecosystem with an ever-growing global community. BioVox is a non-profit project: we are able to provide our community with free, quality content because of the generous support of Turnstone Communications and its clients. Our articles bring you hidden opportunities and exclusive insights into the latest research and industry trends!
All posts